Course information
Teaching objective
This course provides information on the basics and new findings in modern gene therapy, its different types, as well as target diseases, and the advantages and disadvantages of various viral vector systems.
Primary target group:
Physicians of all disciplines
Scientific director/lecturer:
Prof. Evangelia Yannaki, MD
Gene and Cell Therapy Center, Director
Hematology Dpt-BMT Unit,
Papanikolaou Hospital, Thessaloniki, Greece
DFP-points:
For correctly answering the multiple-choice questions 1 point is awarded for the Diploma Continuing Education Programme of the Austrian Medical Association.
Medical speciality:
all disciplines
Lecture Board:
Univ.-Prof. Dr. Ingrid Pabinger-Fasching
Klinische Abteilung für Hämatologie und Hämostaseologie
Universitätsklinik für Innere Medizin I
Medizinische Universität Wien
Univ. Prof. Dr. Christoph Male-Dressler, MSc
Gerinnungsambulanz für Kinder und Jugendliche, Klinische Abteilung für Pädiatrische Kardiologie
Universitätsklinik für Kinder- und Jugendheilkunde
Medizinische Universität Wien
Medical training provider:
Gesellschaft der Ärzte
Organisation:
Universimed Cross Media Content GmbH
Cost:
This course is provided to you free of charge.
Disclosure Statement:
All persons presenting at this course or contributing to the content have been asked to disclose any conflicts of interest that may exist that could be associated with influencing the course content.
Sponsor:
Pfizer Corporation Austria Ges.m.b.H.
Valid until:
Mai 2024
PP-RDP-AUT-0075/01.2022